ALIVUS LIFE SCIENCES
Back to Income Statement
|
ALIVUS LIFE SCIENCES Last 5 Year Revenue History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,552 Cr | ₹2,387 Cr | ₹2,283 Cr | ₹2,161 Cr | ₹2,123 Cr |
What is the latest Revenue of ALIVUS LIFE SCIENCES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,552 Cr |
| Mar2025 | ₹2,387 Cr |
| Mar2024 | ₹2,283 Cr |
| Mar2023 | ₹2,161 Cr |
| Mar2022 | ₹2,123 Cr |
How is Revenue of ALIVUS LIFE SCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,552 Cr | 6.91 | |
| Mar2025 | ₹2,387 Cr | 4.54 | |
| Mar2024 | ₹2,283 Cr | 5.64 | |
| Mar2023 | ₹2,161 Cr | 1.79 | |
| Mar2022 | ₹2,123 Cr | - | |
Compare Revenue of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹16,826.1 Cr | -1% | 20.5% | 43.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | -1% |
20.5% |
43.2% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses